Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Depatuxizumab Mafodotin (ABT-414)-induced Glioblastoma Cell Death Requires EGFR Overexpression, but not EGFR Y1068 Phosphorylation

Subjects: Clinic for Neurology; 610 Medicine & health

  • Source: von Achenbach, Caroline; Silginer, Manuela; Blot, Vincent; Weiss, William A; Weller, Michael (2020). Depatuxizumab Mafodotin (ABT-414)-induced Glioblastoma Cell Death

Record details

×
Academic Journal

Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastoma

Subjects: Clinic for Neurology; 610 Medicine & health

  • Source: Clement, Paul M J; Dirven, Linda; Eoli, Marica; Sepulveda-Sanchez, Juan M; Walenkamp, Annemiek M E; Frenel, Jean S; Franceschi, Enrico; Weller, Michael; et al (2021). Impact of depatuxizumab mafodotin

Record details

×
  • 1-2 of  2 results for ""ABT-414""